MedTrace Logo

Bioequivalence of Eye Drops and Spray Administration of Vigamox

NCT00666042 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2012-01-19

No results posted yet for this study

Summary

The study compares the amounts of Vigamox absorbed when administered as eye drops or in a spray form. Both administrations will be prior to patients undergoing elective cataract surgery and the aqueous samples will be analyzed by a laboratory in a masked fashion. The hypothesis is that there will be no difference between the 2 modes of administration.

Conditions

  • Cataract

Interventions

DRUG

Vigamox - administration in spray form

Vigamox will be administered in a spray form

DRUG

Vigamox eye drops

Vigamox eye drops

Sponsors & Collaborators

  • Advanced Ophthalmic Pharma

    lead INDUSTRY

Principal Investigators

  • Adi Michaeli, MD · TAMC, Tel Aviv, Israel

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2009-04-30
Completion
2009-05-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00666042 on ClinicalTrials.gov